The US Food and Drug Administration (FDA) has updated its guidance regarding how it regulates certain health-related technology. Under the revised guidance, a product may be classified as a general
The US Food and Drug Administration (FDA) has approved weight-loss drug Wegovy as the first once-daily oral GLP-1 weight-loss pill. The FDA approved the first oral GLP‑1 medication for chronic
The US Food and Drug Administration (FDA) has issued warning letters to website owners illegally marketing unapproved and misbranded botulinum toxin (BoNT) products. Online, the agency stated that it is